Sulfonylurea adherence and glycemic control in native Americans with type 2 diabetes mellitus

Michael W. Kruse, Michael S. Monaghan, Thomas J. Troshynski

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to assess adherence to sulfonylurea monotherapy within a Native American population with type 2 diabetes mellitus. Patient medication adherence was evaluated using medical records to perform a 12-month, cross-sectional evaluation of medication refills. Adherence was defined using a continuous, multiple-interval measure of medication availability (CMA). Patients had an average of 80.5 ± 25.4 days of medication during 100 days of treatment, equivalent to a defined adherence scale of fair to poor in 58%. Because CMA may be less expensive and time- consuming than other measures of medication adherence, CMA can be used to assess medication adherence in patients at risk for developing diabetes complications, such as Native Americans.

Original languageEnglish
Pages (from-to)41-49
Number of pages9
JournalJournal of Pharmacoepidemiology
Volume8
Issue number1
DOIs
StatePublished - 2000

Fingerprint

Medication Adherence
North American Indians
Type 2 Diabetes Mellitus
Diabetes Complications
Patient Compliance
Medical Records
Population
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Sulfonylurea adherence and glycemic control in native Americans with type 2 diabetes mellitus. / Kruse, Michael W.; Monaghan, Michael S.; Troshynski, Thomas J.

In: Journal of Pharmacoepidemiology, Vol. 8, No. 1, 2000, p. 41-49.

Research output: Contribution to journalArticle

@article{4a6cc7d42e88479dbe0d183e1add70f9,
title = "Sulfonylurea adherence and glycemic control in native Americans with type 2 diabetes mellitus",
abstract = "The purpose of this study was to assess adherence to sulfonylurea monotherapy within a Native American population with type 2 diabetes mellitus. Patient medication adherence was evaluated using medical records to perform a 12-month, cross-sectional evaluation of medication refills. Adherence was defined using a continuous, multiple-interval measure of medication availability (CMA). Patients had an average of 80.5 ± 25.4 days of medication during 100 days of treatment, equivalent to a defined adherence scale of fair to poor in 58{\%}. Because CMA may be less expensive and time- consuming than other measures of medication adherence, CMA can be used to assess medication adherence in patients at risk for developing diabetes complications, such as Native Americans.",
author = "Kruse, {Michael W.} and Monaghan, {Michael S.} and Troshynski, {Thomas J.}",
year = "2000",
doi = "10.1300/J055v08n01_03",
language = "English",
volume = "8",
pages = "41--49",
journal = "Journal of Pharmacoepidemiology",
issn = "0896-6966",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Sulfonylurea adherence and glycemic control in native Americans with type 2 diabetes mellitus

AU - Kruse, Michael W.

AU - Monaghan, Michael S.

AU - Troshynski, Thomas J.

PY - 2000

Y1 - 2000

N2 - The purpose of this study was to assess adherence to sulfonylurea monotherapy within a Native American population with type 2 diabetes mellitus. Patient medication adherence was evaluated using medical records to perform a 12-month, cross-sectional evaluation of medication refills. Adherence was defined using a continuous, multiple-interval measure of medication availability (CMA). Patients had an average of 80.5 ± 25.4 days of medication during 100 days of treatment, equivalent to a defined adherence scale of fair to poor in 58%. Because CMA may be less expensive and time- consuming than other measures of medication adherence, CMA can be used to assess medication adherence in patients at risk for developing diabetes complications, such as Native Americans.

AB - The purpose of this study was to assess adherence to sulfonylurea monotherapy within a Native American population with type 2 diabetes mellitus. Patient medication adherence was evaluated using medical records to perform a 12-month, cross-sectional evaluation of medication refills. Adherence was defined using a continuous, multiple-interval measure of medication availability (CMA). Patients had an average of 80.5 ± 25.4 days of medication during 100 days of treatment, equivalent to a defined adherence scale of fair to poor in 58%. Because CMA may be less expensive and time- consuming than other measures of medication adherence, CMA can be used to assess medication adherence in patients at risk for developing diabetes complications, such as Native Americans.

UR - http://www.scopus.com/inward/record.url?scp=0033992135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033992135&partnerID=8YFLogxK

U2 - 10.1300/J055v08n01_03

DO - 10.1300/J055v08n01_03

M3 - Article

VL - 8

SP - 41

EP - 49

JO - Journal of Pharmacoepidemiology

JF - Journal of Pharmacoepidemiology

SN - 0896-6966

IS - 1

ER -